Compare Lupin Ltd with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs PANACEA BIOTECH - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN PANACEA BIOTECH LUPIN/
PANACEA BIOTECH
 
P/E (TTM) x -132.7 8.9 - View Chart
P/BV x 3.0 3.5 85.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   PANACEA BIOTECH
EQUITY SHARE DATA
    LUPIN
Mar-19
PANACEA BIOTECH
Mar-19
LUPIN/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs986354 278.8%   
Low Rs720138 521.3%   
Sales per share (Unadj.) Rs369.574.6 495.5%  
Earnings per share (Unadj.) Rs13.46.7 200.7%  
Cash flow per share (Unadj.) Rs37.415.5 241.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs303.757.2 530.9%  
Shares outstanding (eoy) m452.4961.25 738.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.33.3 70.0%   
Avg P/E ratio x63.636.8 172.9%  
P/CF ratio (eoy) x22.815.9 143.8%  
Price / Book Value ratio x2.84.3 65.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m386,06415,061 2,563.3%   
No. of employees `00017.72.3 764.2%   
Total wages/salary Rs m31,5131,471 2,142.6%   
Avg. sales/employee Rs Th9,453.81,973.6 479.0%   
Avg. wages/employee Rs Th1,782.0635.6 280.4%   
Avg. net profit/employee Rs Th343.0176.8 194.0%   
INCOME DATA
Net Sales Rs m167,1824,567 3,660.6%  
Other income Rs m3,64045 8,125.4%   
Total revenues Rs m170,8224,612 3,704.0%   
Gross profit Rs m28,8222,030 1,420.0%  
Depreciation Rs m10,850540 2,009.3%   
Interest Rs m3,0781,048 293.6%   
Profit before tax Rs m18,534486 3,812.0%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,01777 11,695.1%   
Profit after tax Rs m6,066409 1,482.6%  
Gross profit margin %17.244.4 38.8%  
Effective tax rate %48.715.9 306.8%   
Net profit margin %3.69.0 40.5%  
BALANCE SHEET DATA
Current assets Rs m138,5362,415 5,737.7%   
Current liabilities Rs m61,2999,077 675.3%   
Net working cap to sales %46.2-145.9 -31.7%  
Current ratio x2.30.3 849.7%  
Inventory Days Days8465 128.7%  
Debtors Days Days11271 158.5%  
Net fixed assets Rs m127,5168,333 1,530.2%   
Share capital Rs m90561 1,476.3%   
"Free" reserves Rs m136,5173,443 3,965.4%   
Net worth Rs m137,4223,504 3,921.9%   
Long term debt Rs m66,417461 14,401.0%   
Total assets Rs m279,49413,755 2,031.9%  
Interest coverage x7.01.5 479.6%   
Debt to equity ratio x0.50.1 367.2%  
Sales to assets ratio x0.60.3 180.2%   
Return on assets %3.310.6 30.9%  
Return on equity %4.411.7 37.8%  
Return on capital %8.938.7 23.0%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m59,4141,203 4,938.7%   
Fx outflow Rs m22,282467 4,774.8%   
Net fx Rs m37,132736 5,042.5%   
CASH FLOW
From Operations Rs m16,6601,049 1,588.5%  
From Investments Rs m-32,825-54 61,354.6%  
From Financial Activity Rs m7,441-1,011 -735.7%  
Net Cashflow Rs m-8,724-20 44,282.7%  

Share Holding

Indian Promoters % 46.6 74.5 62.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 0.6 1,883.3%  
FIIs % 31.9 1.3 2,453.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 23.6 42.8%  
Shareholders   98,259 10,259 957.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   WOCKHARDT  J.B.CHEMICALS  SHASUN PHARMA  BIOCON   FULFORD INDIA  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jul 3, 2020 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS